Literature DB >> 7276161

Altered spectrin dimer-dimer association and instability of erythrocyte membrane skeletons in hereditary pyropoikilocytosis.

S C Liu, J Palek, J Prchal, R P Castleberry.   

Abstract

Hereditary pyropoikilocytosis (HPP) is a hemolytic anemia characterized by microspherocytosis, poikilocytosis, and an unusual thermal sensitivity of erythrocytes. We have investigated the contribution of abnormal membrane skeletal assembly to these abnormal HPP erythrocyte properties. Skeletons prepared from fresh HPP ghosts with Triton X-100 were considerably more fragile than skeletons from control erythrocytes. Spectrin, the major skeleton component, extracted at 0 degrees C from normal erythrocytes, was present primarily as tetramers and high molecular weight complexes. In contrast, spectrin extracted from HPP erythrocytes under identical conditions contained a significant amount of dimers with a concomitant decrease of tetramers. Furthermore, spectrin dimers from HPP erythrocytes differed from normal spectrin dimers in their failure to reassociate into tetramers both in solution and in the membrane. Presumptive HPP carriers (asymptomatic mothers of the two patients) exhibited a mild but reproducible increase of spectrin dimers in 0 degrees C extracts and a defective reassociation of spectrin dimers of tetramers both in solution and in the membrane. We conclude that in HPP, self-association of spectrin dimers into tetramers is defective, which accounts for the instability of membrane skeletons.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7276161      PMCID: PMC370839          DOI: 10.1172/jci110293

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Spontaneous, reversible protein cross-linking in the human erythrocyte membrane. Temperature and pH dependence.

Authors:  S C Liu; G Fairbanks; J Palek
Journal:  Biochemistry       Date:  1977-09-06       Impact factor: 3.162

Review 2.  Spectrin-actin membrane skeleton of normal and abnormal red blood cells.

Authors:  S E Lux
Journal:  Semin Hematol       Date:  1979-01       Impact factor: 3.851

3.  Spectrin-actin interaction. Phosphorylated and dephosphorylated spectrin tetramer cross-link F-actin.

Authors:  S L Brenner; E D Korn
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Heat-induced erythrocyte fragmentation in neonatal elliptocytosis.

Authors:  H S Zarkowsky
Journal:  Br J Haematol       Date:  1979-04       Impact factor: 6.998

6.  Effect of heat on the circular dichroism of spectrin in hereditary pyropoikilocytosis.

Authors:  K Chang; J R Williamson; H S Zarkowsky
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Self-association of human spectrin. A thermodynamic and kinetic study.

Authors:  E Ungewickell; W Gratzer
Journal:  Eur J Biochem       Date:  1978-08-01

8.  In vitro formation of a complex between cytoskeletal proteins of the human erythrocyte.

Authors:  E Ungewickell; P M Bennett; R Calvert; V Ohanian; W B Gratzer
Journal:  Nature       Date:  1979-08-30       Impact factor: 49.962

9.  A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane.

Authors:  H S Zarkowsky; N Mohandas; C B Speaker; S B Shohet
Journal:  Br J Haematol       Date:  1975-04       Impact factor: 6.998

10.  DNase-I-dependent dissociation of erythrocyte cytoskeletons.

Authors:  M P Sheetz
Journal:  J Cell Biol       Date:  1979-04       Impact factor: 10.539

View more
  36 in total

1.  Regulation of protein mobility in cell membranes: a dynamic corral model.

Authors:  D M Leitner; F L Brown; K R Wilson
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Growth of Plasmodium falciparum in human erythrocytes containing abnormal membrane proteins.

Authors:  S Schulman; E F Roth; B Cheng; A C Rybicki; I I Sussman; M Wong; W Wang; H M Ranney; R L Nagel; R S Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Molecular defect in the sickle erythrocyte skeleton. Abnormal spectrin binding to sickle inside-our vesicles.

Authors:  O S Platt; J F Falcone; S E Lux
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

4.  Membrane protein lesions in erythrocytes with Heinz bodies.

Authors:  O S Platt; J F Falcone
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  The spectrin network as a barrier to lateral diffusion in erythrocytes. A percolation analysis.

Authors:  M J Saxton
Journal:  Biophys J       Date:  1989-01       Impact factor: 4.033

6.  Molecular defect in the membrane skeleton of blood bank-stored red cells. Abnormal spectrin-protein 4.1-actin complex formation.

Authors:  L C Wolfe; A M Byrne; S E Lux
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells.

Authors:  J G Conboy; J Chan; N Mohandas; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.

Authors:  T L Coetzer; K Sahr; J Prchal; H Blacklock; L Peterson; R Koler; J Doyle; J Manaster; J Palek
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Defective binding of spectrin to ankyrin in a kindred with recessively inherited hereditary elliptocytosis.

Authors:  S S Zail; T L Coetzer
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

10.  Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations.

Authors:  J A Chasis; N Mohandas
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.